| Identification | Back Directory | [Name]
Unii-9927mt646m | [CAS]
179045-86-4 | [Synonyms]
Simulect
Bailiximab
SDZ-CHI 621
Unii-9927mt646m
from USAN List 422
Immunoglobulin G 1 (human-mouse monoclonal chi621 heavy chain anti-human interleukin 2 receptor), disulfide with human-mouse monoclonal chi621 light chain, dimer |
| Hazard Information | Back Directory | [Uses]
Immunosuppressant (monoclonal
antibody). | [Brand name]
Simulect (Novartis). | [in vivo]
Basiliximab (CHI 621) (0.07 mg/rat; i.v.; once) decreases total placental natural killer cells in reduced uterine perfusion pressure (RUPP) rats[2]. | Animal Model: | Timed-pregnant Sprague Dawley (SD) rats, reduced uterine perfusion pressure (RUPP) rat model of placental ischemia[2] | | Dosage: | 0.07 mg/rat | | Administration: | IV infusion, once | | Result: | Decreased total placental natural killer cells. Had no effect to lower MAP or improve pup weight and placental weight. |
| [storage]
Store at -20°C |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 18108604356 |
| Website: |
www.biolabreagent.com/ |
|